<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7093363/results/search/test_trace/results.xml">
  <result pre="prevented SARS-CoV infection, reduced viral replication, and reduced histopathology during" exact="treatment" post="(Cinatl et al., 2003b; Haagmans et al., 2004). To"/>
  <result pre="potential to show therapeutic effects against 2019-nCoV, were chosen for" exact="testing" post="for the clinical treatment of pneumonia in patients infected"/>
  <result pre="effects against 2019-nCoV, were chosen for testing for the clinical" exact="treatment" post="of pneumonia in patients infected with 2019-nCoV. Based on"/>
  <result pre="significantly inhibit the replication and tissue damage caused by coronavirus" exact="infection" post="in bronchi and lungs of humans. Pfefferle et al."/>
  <result pre="for sustained human-to-human transmission is critically important for coordinating current" exact="screening" post="and containment strategies, and for determining whether the outbreak"/>
  <result pre="transmission network model for simulating the potential transmission from the" exact="infection" post="source to the humans (Chen et al., 2020a). In"/>
  <result pre="immunological questions associated with viral infections. The clinical characteristics and" exact="treatment" post="of 2019-nCoV and SARS both suggested a serious problem"/>
  <result pre="of the most dangerous but valuable experiments is to perform" exact="tests" post="on immune cells in the blood and lungs of"/>
  <result pre="JongTItamuraSChanKHet al.Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus" exact="infection" post="in macaquesNat Med20041029029310.1038/nm100114981511 HilgenfeldRPeirisMFrom SARS to MERS: 10 years"/>
  <result pre="respiratory disease in Wuhan, China. bioRxiv ZhaoZZhangFXuMHuangKZhongWCaiWYinZHuangSDengZWeiMet al.Description and clinical" exact="treatment" post="of an early outbreak of severe acute respiratory syndrome"/>
 </snippets>
</snippetsTree>
